Last Updated: 10 Nov 2024
Executive Summary
OraSure Technologies Inc. (OSUR) is a medical diagnostics company focused on developing and marketing oral fluid diagnostic products. The company has a strong presence in the United States, Europe, and internationally. OSUR's latest stock price is $4.29, and analysts have a "Hold" rating on the stock with a target price of $6.33.
Company Overview
OraSure Technologies, Inc. was founded in 1987 and is headquartered in Bethlehem, Pennsylvania. The company develops, manufactures, markets, and sells oral fluid diagnostic products and sample collection devices. OSUR's products are used for a variety of applications, including HIV testing, drug testing, and infectious disease testing. The company has a strong patent portfolio and a global distribution network.
Fundamental Analysis
OSUR's financial performance has been mixed in recent years. The company has reported revenue growth in each of the past three years, but its earnings have been volatile. In 2023, OSUR reported revenue of $224.3 million and net income of $9.8 million. The company's gross profit margin was 65.4%, and its operating margin was -14.1%. OSUR's balance sheet is strong, with $126.7 million in cash and equivalents and no long-term debt.
OSUR's valuation metrics are relatively attractive. The company's trailing price-to-earnings ratio is 28.6, and its forward price-to-earnings ratio is not available. OSUR's price-to-sales ratio is 1.43, and its price-to-book ratio is 0.75.
Technical Analysis
OSUR's stock price has been trending lower in recent months. The stock is currently trading below its 50-day moving average and its 200-day moving average. The stock's relative strength index (RSI) is 35.7, which indicates that the stock is oversold.
Short Term Outlook
OSUR's stock price is likely to remain under pressure in the short term. The company's earnings are volatile, and the stock is trading below its moving averages. The RSI is also indicating that the stock is oversold, which could lead to a short-term bounce. However, the stock's long-term outlook is more positive.
Long Term Outlook
OSUR is a well-established company with a strong patent portfolio and a global distribution network. The company's products are used for a variety of applications, and the demand for these products is likely to continue to grow. OSUR's financial performance is expected to improve in the long term, and the stock is likely to appreciate in value.
Analyst Recommendations
Analysts have a "Hold" rating on OSUR stock with a target price of $6.33. The consensus price target is based on the company's strong fundamentals and its long-term growth potential.
